Drug delivery systems and combination therapy by using vinca alkaloids

Item

http://www.wikidata.org/entity/Q28829009

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Drug delivery systems and combination therapy by using vinca alkaloids

@ast

Drug delivery systems and combination therapy by using vinca alkaloids

@en

type

Item

label

Drug delivery systems and combination therapy by using vinca alkaloids

@ast

Drug delivery systems and combination therapy by using vinca alkaloids

@en

prefLabel

Drug delivery systems and combination therapy by using vinca alkaloids

@ast

Drug delivery systems and combination therapy by using vinca alkaloids

@en

P1476

Drug delivery systems and combination therapy by using vinca alkaloids

@en

P2093

Chih-Hui Yang

http://www.w3.org/2001/XMLSchema#string

Chun-Ting Lee

http://www.w3.org/2001/XMLSchema#string

Keng-Shiang Huang

http://www.w3.org/2001/XMLSchema#string

Yen-Wei Huang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Vinca alkaloids

Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine

Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol

Improved brain delivery of vincristine using dextran sulfate complex solid lipid nanoparticles: optimization and in vivo evaluation.

Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol.

Catharanthus roseus flower extract has wound-healing activity in Sprague Dawley rats.

A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.

Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM).

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.

P304

1491-500

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2174/1568026615666150414120547

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275053878

http://www.w3.org/2001/XMLSchema#string

P698

25877096

http://www.w3.org/2001/XMLSchema#string

P921

Aillse

drug delivery

drug discovery

heterocyclic compound

Vinflunine

P932

4997956

http://www.w3.org/2001/XMLSchema#string